Notably, the AMPKα/MMP9 axis attenuates skeletal muscle fibrosis, while PPAR-γ/NLRP3/NF-κB signaling mitigates pulmonary fibrosis progression (121, 122). The gene discussed is NLRP3; the disease is pulmonary fibrosis.